Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11105041rdf:typepubmed:Citationlld:pubmed
pubmed-article:11105041lifeskim:mentionsumls-concept:C0005850lld:lifeskim
pubmed-article:11105041lifeskim:mentionsumls-concept:C1458155lld:lifeskim
pubmed-article:11105041lifeskim:mentionsumls-concept:C0006906lld:lifeskim
pubmed-article:11105041lifeskim:mentionsumls-concept:C0232338lld:lifeskim
pubmed-article:11105041lifeskim:mentionsumls-concept:C0242485lld:lifeskim
pubmed-article:11105041lifeskim:mentionsumls-concept:C0009924lld:lifeskim
pubmed-article:11105041lifeskim:mentionsumls-concept:C0024485lld:lifeskim
pubmed-article:11105041lifeskim:mentionsumls-concept:C0521115lld:lifeskim
pubmed-article:11105041pubmed:issue6lld:pubmed
pubmed-article:11105041pubmed:dateCreated2001-2-2lld:pubmed
pubmed-article:11105041pubmed:abstractTextA technique for the simultaneous measurement of three vascular parameters: blood flow (Frho), blood volume (v(b)), and the capillary permeability-surface area product (PSrho) in breast tumors using dynamic contrast-enhanced magnetic resonance imaging (MRI) is presented. Features of the technique include measurement of precontrast tumor T(1), rapid temporal sampling, measurement of the arterial input function, and use of a distributed parameter tracer kinetic model. Parameter measurements are compared that were determined using two contrast agents of different molecular weights, gadolinium-diethylene triamine pentaacetic acid (Gd-DTPA; 0.6 kDa) and Gadomer-17 (17 kDa), in 18 spontaneous canine mammary tumors. Measurements of Frho and v(b) corresponded well with literature values, and the mean PSrho measured using Gd-DTPA was a factor of 15 higher than that measured using Gadomer-17. J. Magn. Reson. Imaging 2000;12:991-1003.lld:pubmed
pubmed-article:11105041pubmed:languageenglld:pubmed
pubmed-article:11105041pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11105041pubmed:citationSubsetIMlld:pubmed
pubmed-article:11105041pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11105041pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11105041pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11105041pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11105041pubmed:statusMEDLINElld:pubmed
pubmed-article:11105041pubmed:monthDeclld:pubmed
pubmed-article:11105041pubmed:issn1053-1807lld:pubmed
pubmed-article:11105041pubmed:authorpubmed-author:LeeT YTYlld:pubmed
pubmed-article:11105041pubmed:authorpubmed-author:HendersonEElld:pubmed
pubmed-article:11105041pubmed:authorpubmed-author:SykesJJlld:pubmed
pubmed-article:11105041pubmed:authorpubmed-author:RuttB KBKlld:pubmed
pubmed-article:11105041pubmed:authorpubmed-author:WeinmannH JHJlld:pubmed
pubmed-article:11105041pubmed:authorpubmed-author:DrostDDlld:pubmed
pubmed-article:11105041pubmed:copyrightInfoCopyright 2000 Wiley-Liss, Inc.lld:pubmed
pubmed-article:11105041pubmed:issnTypePrintlld:pubmed
pubmed-article:11105041pubmed:volume12lld:pubmed
pubmed-article:11105041pubmed:ownerNLMlld:pubmed
pubmed-article:11105041pubmed:authorsCompleteYlld:pubmed
pubmed-article:11105041pubmed:pagination991-1003lld:pubmed
pubmed-article:11105041pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11105041pubmed:meshHeadingpubmed-meshheading:11105041...lld:pubmed
pubmed-article:11105041pubmed:meshHeadingpubmed-meshheading:11105041...lld:pubmed
pubmed-article:11105041pubmed:meshHeadingpubmed-meshheading:11105041...lld:pubmed
pubmed-article:11105041pubmed:meshHeadingpubmed-meshheading:11105041...lld:pubmed
pubmed-article:11105041pubmed:meshHeadingpubmed-meshheading:11105041...lld:pubmed
pubmed-article:11105041pubmed:meshHeadingpubmed-meshheading:11105041...lld:pubmed
pubmed-article:11105041pubmed:meshHeadingpubmed-meshheading:11105041...lld:pubmed
pubmed-article:11105041pubmed:meshHeadingpubmed-meshheading:11105041...lld:pubmed
pubmed-article:11105041pubmed:meshHeadingpubmed-meshheading:11105041...lld:pubmed
pubmed-article:11105041pubmed:meshHeadingpubmed-meshheading:11105041...lld:pubmed
pubmed-article:11105041pubmed:meshHeadingpubmed-meshheading:11105041...lld:pubmed
pubmed-article:11105041pubmed:meshHeadingpubmed-meshheading:11105041...lld:pubmed
pubmed-article:11105041pubmed:meshHeadingpubmed-meshheading:11105041...lld:pubmed
pubmed-article:11105041pubmed:meshHeadingpubmed-meshheading:11105041...lld:pubmed
pubmed-article:11105041pubmed:meshHeadingpubmed-meshheading:11105041...lld:pubmed
pubmed-article:11105041pubmed:year2000lld:pubmed
pubmed-article:11105041pubmed:articleTitleSimultaneous MRI measurement of blood flow, blood volume, and capillary permeability in mammary tumors using two different contrast agents.lld:pubmed
pubmed-article:11105041pubmed:affiliationImaging Division, Lawson Health Research Institute, St. Joseph's Health Care, London, Ontario, Canada, N6A 4V2.lld:pubmed
pubmed-article:11105041pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11105041pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:11105041pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11105041lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11105041lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11105041lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11105041lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11105041lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11105041lld:pubmed